Peg filgrastim (Peg-GCSF) Injection 6 mg/0.6 ml PEG-NUSTIM®is used to prevent neutropenia (a lack of certain white blood cells) arising as a result of chemotherapy administration Indication:PEG-NUSTIM®is indicated to decrease the risk of patients developing febrile neutropenia when receiving...
【摘要】目的：观察PEG-rhG-CSF（新瑞白）对比rhG-CSF用于预防肿瘤患者化疗后所引起的中性粒细胞减少症治疗的优势、不良反应及对化疗周期的影响。方法：试验组及对照组各30例：化疗周期第2～3天，既往化疗后骨髓抑制达II～IV度，单次皮下注射PEG-rhG-CSF 3mg，对比同时期化疗后应用rhG-CSF升白细胞治疗患者。结果...
Pharmacokinetics and Pharmacodynamics of Single Doses of Subcutaneous Pegylated Human GCSF Mutant (PEG30-rhG-CSF) in Beagle dogs[J].Journal of Clinical Oncology,2008,(05):326-332.Yongming Cai et al.Pharmacokinetics and pharmacodynamics of subcutaneous single doses of pegylated human G-CSF mutant...
Pharmacokinetics and Pharmacodynamics of Single Doses of Subcutaneous Pegylated Human GCSF Mutant (PEG30-rhG-CSF) in Beagle dogs[J].Journal of Clinical Oncology 2008,5(05).Yongming Cai et al.Pharmacokinetics and pharmacodynamics of subcutaneous single doses of pegylated human G-CSF mutant(PEG30-...
Pharmacokinetics and Pharmacodynamics of Single Doses of Subcutaneous Pegylated Human GCSF Mutant (PEG30-rhG-CSF) in Beagle dogs[J].Journal of Clinical Oncology,2008,(05):326-332.Cai YM,Chen ZM,Jiang L. Pharmacokinetics and Pharmacodynamics of Single Doses of Subcutaneous Pegylated Human GCSF ...
PEG-filgrastim has been used at Children's Hospital at Westmead (CHW) since December 2002. At CHW we mobilise and harvest PBSC's from approximately 35 patients per annum following colony stimulating factors, predominantly GCSF +/- chemotherapy. We observed that in 5 patients after routine ...